Vitamin K Status and Markers of Vascular Function in Patients With and Without Postural Hypotension
NCT ID: NCT02505282
Last Updated: 2015-07-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
49 participants
OBSERVATIONAL
2012-04-30
2014-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Recent trial evidence has suggested that vitamin K may exert beneficial effects on vascular health particularly in respect to inhibiting calcification. Calcification increases vascular stiffness, decreases compliance and thus decreases the ability of blood vessels to autoregulate blood pressure and flow - which could contribute to postural drops in blood pressure. Worsened vascular health could also impact adversely on baroceptor function, which is needed for blood pressure autoregulation and which is disrupted in patients with orthostatic hypotension.
Vitamin K intake is below recommended daily intake in 60% of adults in the UK. In animals, vitamin K supplementation may be able to reverse calcification of arteries, and in humans Vitamin K has been shown to arrest decline in carotid artery elasticity compared to placebo. High levels of circulating vitamin K were also associated with lower levels of CRP in the Framingham cohort, suggesting a possible role in the suppression of chronic inflammation that is known to accompany vascular disease. The recent ECKO study suggested that vitamin K may reduce falls and fractures; an intriguing question that follows on from this is whether this could be due to beneficial effects on vascular health and postural hypotension, leading to less dizziness and reduced falls.
This cross-sectional comparative study aims to find whether there is a difference in the vitamin K status of patients with postural hypotension compared to those without postural hypotension and whether differences in vitamin K status are associated with other markers of vascular function in patients with and without postural hypotension. This could potentially lead to new treatments for the condition for which there is currently little of proven benefit.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Vitamin D Supplementation on Blood Pressure in Elderly People
NCT02047799
Effect of Vitamin K on Age-Related Bone Loss and Vascular Calcification
NCT00183001
Vitamin D Deficiency and Dysautonomia
NCT03032328
Effects of Vitamin D on Renin Expression in Hypertensive Patients
NCT00585442
Vitamin D and Microvascular Function in Postmenopausal Women
NCT05408273
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Orthostatic Hypotension
\>20mmHg systolic BP drop or \>10mmHg diastolic BP drop on standing, and syncopal symptoms on standing
Vitamin K status
Vitamin K status indicated by desphospho-uncarboxylated matrix Gla protein level
Control
No fall in BP or \<20mmHg systolic BP drop and \<10mmHg diastolic BP drop on standing, and no syncopal symptoms on standing
Vitamin K status
Vitamin K status indicated by desphospho-uncarboxylated matrix Gla protein level
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin K status
Vitamin K status indicated by desphospho-uncarboxylated matrix Gla protein level
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* For postural hypotension group: \>20mmHg systolic BP drop or \>10mmHg diastolic BP drop on standing, and syncopal symptoms on standing.
* For control group: no fall in BP or \<20mmHg systolic BP drop and \<10mmHg diastolic BP drop on standing, and no syncopal symptoms on standing. No previous diagnosis of orthostatic hypotension.
Exclusion Criteria
* Unable to consent
* Unable to stand unaided
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
British Geriatrics Society
OTHER
University of Dundee
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Matthew Lambert
Clinical Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Univeristy of Dundee
Dundee, Angus, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011CV14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.